Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML) is a research paper published in Leukemia (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P01-CA078902
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P01-CA018029
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P30-CA015704
NCI NIH HHS
Grant: P01 CA078902
NCI NIH HHS
Grant: P30 CA015704
NCI NIH HHS
Grant: P01 CA018029
National Institutes of Health
Grant: 2P01CA078902-16
Core C: Administrative Services
National Institutes of Health
Grant: 5P01CA018029-36
Targeting Alloreactivity for Leukemia Eradication
National Institutes of Health
Grant: 3P30CA015704-42S2
Cancer Center Support Grant
U.S. Department of Health & Human Services | NIH | National Cancer Institute
FWCI
3.44
Citation Percentile
0.9%
Influential Citations
3
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals